Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This is a study to evaluate how recombinant tissue plasminogen activator (rt-PA) is utilized
in patients with intraventricular hemorrhage (IVH). rt-PA is a drug that has been shown to
dissolve blood, and may allow intraventricular catheters to be more effective for a longer
period of time.